Very early researchWithdrawnNCT00993642
What this trial is testing
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
Who this might be right for
Breast Cancer
Tulane University Health Sciences Center
Showing 20 of 0 results